June 29, 2026

White House bats down speculation that Trump got access to Eli Lilly obesity drug for ‘compassionate use’

White House bats down speculation that Trump got access to Eli Lilly obesity drug for ‘compassionate use’

White House officials on Tuesday shot down a report speculating that President Trump gained access to the retatrutide weight-loss drug under the Food and Drug Administration’s (FDA) “compassionate use program.” The retatrutide drug is manufactured by Eli Lilly and is not FDA approved, however, one person gained access to the prescription through a program that…

Previous Article

Trump’s extraordinary welcome for white South Africans

Next Article

‘Who’s the Boss?’ Star Danny Pintauro Says Being an Amazon Delivery Driver Is ‘One of Five Jobs’ He Has Now Has Because ‘I Don’t Make Money From Residuals’

You might be interested in …

Yes, Ban All Federal “Labor Unions”

Yes, Ban All Federal “Labor Unions”

In a bold move, advocates argue for a complete ban on federal labor unions, citing concerns over inefficiency and potential conflicts of interest. Proponents believe dismantling these unions could lead to a more competitive workforce and improved fiscal responsibility.